# | Title | Journal | Year | Citations |
---|
1 | Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Ca-A Cancer Journal for Clinicians | 2018 | 62,121 |
2 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries | Ca-A Cancer Journal for Clinicians | 2021 | 52,977 |
3 | Global cancer statistics | Ca-A Cancer Journal for Clinicians | 2011 | 32,172 |
4 | Global cancer statistics, 2012 | Ca-A Cancer Journal for Clinicians | 2015 | 23,881 |
5 | Cancer statistics, 2019 | Ca-A Cancer Journal for Clinicians | 2019 | 17,512 |
6 | Cancer statistics, 2020 | Ca-A Cancer Journal for Clinicians | 2020 | 16,450 |
7 | Global Cancer Statistics, 2002 | Ca-A Cancer Journal for Clinicians | 2005 | 15,952 |
8 | Cancer statistics, 2016 | Ca-A Cancer Journal for Clinicians | 2016 | 14,876 |
9 | Cancer statistics, 2018 | Ca-A Cancer Journal for Clinicians | 2018 | 14,774 |
10 | Cancer statistics in China, 2015 | Ca-A Cancer Journal for Clinicians | 2016 | 14,374 |
11 | Cancer statistics, 2017 | Ca-A Cancer Journal for Clinicians | 2017 | 13,864 |
12 | Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics | Bone Marrow Transplantation | 2013 | 12,312 |
13 | Cancer Statistics, 2010 | Ca-A Cancer Journal for Clinicians | 2010 | 12,112 |
14 | Cancer Statistics, 2021 | Ca-A Cancer Journal for Clinicians | 2021 | 12,002 |
15 | Cancer statistics, 2015 | Ca-A Cancer Journal for Clinicians | 2015 | 11,344 |
16 | Cancer statistics, 2013 | Ca-A Cancer Journal for Clinicians | 2013 | 11,318 |
17 | Cancer statistics, 2014 | Ca-A Cancer Journal for Clinicians | 2014 | 10,909 |
18 | Cancer statistics, 2012 | Ca-A Cancer Journal for Clinicians | 2012 | 10,209 |
19 | Cancer statistics, 2022 | Ca-A Cancer Journal for Clinicians | 2022 | 10,001 |
20 | Cancer Statistics, 2008 | Ca-A Cancer Journal for Clinicians | 2008 | 9,724 |
21 | Cancer Statistics, 2009 | Ca-A Cancer Journal for Clinicians | 2009 | 9,422 |
22 | The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia | Blood | 2016 | 7,429 |
23 | Cancer Statistics, 2007 | Ca-A Cancer Journal for Clinicians | 2007 | 7,103 |
24 | A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments] | Blood | 1994 | 6,150 |
25 | International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Journal of Thrombosis and Haemostasis | 2006 | 6,039 |
26 | The 2016 revision of the World Health Organization classification of lymphoid neoplasms | Blood | 2016 | 5,965 |
27 | Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group | British Journal of Haematology | 1976 | 5,316 |
28 | Cancer Statistics, 2005 | Ca-A Cancer Journal for Clinicians | 2005 | 5,195 |
29 | Cancer Statistics, 2006 | Ca-A Cancer Journal for Clinicians | 2006 | 5,083 |
30 | Intravenous Fluids and Acute Kidney Injury | Blood Purification | 2017 | 4,905 |
31 | Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia | Journal of Thrombosis and Haemostasis | 2020 | 4,615 |
32 | Cancer statistics, 2023 | Ca-A Cancer Journal for Clinicians | 2023 | 4,445 |
33 | Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel | Blood | 2017 | 4,375 |
34 | Cancer treatment and survivorship statistics, 2016 | Ca-A Cancer Journal for Clinicians | 2016 | 4,123 |
35 | International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes | Blood | 1997 | 4,078 |
36 | Human mesenchymal stem cells modulate allogeneic immune cell responses | Blood | 2005 | 4,024 |
37 | HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis | Pediatric Blood and Cancer | 2007 | 4,018 |
38 | The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging | Ca-A Cancer Journal for Clinicians | 2017 | 3,940 |
39 | Photodynamic therapy of cancer: An update | Ca-A Cancer Journal for Clinicians | 2011 | 3,902 |
40 | Biologic basis for interleukin-1 in disease | Blood | 1996 | 3,893 |
41 | Incidence of thrombotic complications in critically ill ICU patients with COVID-19 | Thrombosis Research | 2020 | 3,872 |
42 | The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes | Blood | 2009 | 3,864 |
43 | Cancer statistics, 2011 | Ca-A Cancer Journal for Clinicians | 2011 | 3,791 |
44 | Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients | Journal of Thrombosis and Haemostasis | 2005 | 3,778 |
45 | Cancer Statistics, 2004 | Ca-A Cancer Journal for Clinicians | 2004 | 3,622 |
46 | Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray | Blood | 2004 | 3,574 |
47 | 1994 Consensus Conference on Acute GVHD Grading | Bone Marrow Transplantation | 1995 | 3,571 |
48 | WHO-EORTC classification for cutaneous lymphomas | Blood | 2005 | 3,529 |
49 | Cancer statistics, 2000 | Ca-A Cancer Journal for Clinicians | 2000 | 3,504 |
50 | Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness | Blood Purification | 2017 | 3,492 |
51 | Cancer treatment and survivorship statistics, 2019 | Ca-A Cancer Journal for Clinicians | 2019 | 3,303 |
52 | Colorectal cancer statistics, 2020 | Ca-A Cancer Journal for Clinicians | 2020 | 3,302 |
53 | Colorectal cancer statistics, 2017 | Ca-A Cancer Journal for Clinicians | 2017 | 3,300 |
54 | National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report | Biology of Blood and Marrow Transplantation | 2005 | 3,213 |
55 | Proposals for the classification of the myelodysplastic syndromes | British Journal of Haematology | 1982 | 3,130 |
56 | Cancer Statistics, 2003 | Ca-A Cancer Journal for Clinicians | 2003 | 3,093 |
57 | Cancer Statistics, 2001 | Ca-A Cancer Journal for Clinicians | 2001 | 3,005 |
58 | A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis | Blood | 1996 | 2,995 |
59 | Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet | Blood | 2010 | 2,963 |
60 | Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy | Journal of Thrombosis and Haemostasis | 2020 | 2,925 |
61 | Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli | Blood | 2002 | 2,907 |
62 | Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines | Blood | 2008 | 2,887 |
63 | Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 | Annals of Oncology | 2013 | 2,805 |
64 | Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 | Leukemia | 2003 | 2,788 |
65 | Cancer statistics, 1999 | Ca-A Cancer Journal for Clinicians | 1999 | 2,768 |
66 | Cancer Statistics, 2002 | Ca-A Cancer Journal for Clinicians | 2002 | 2,686 |
67 | National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report | Biology of Blood and Marrow Transplantation | 2015 | 2,636 |
68 | Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients | Radiotherapy and Oncology | 2009 | 2,607 |
69 | Graft-versus-leukemia reactions after bone marrow transplantation | Blood | 1990 | 2,566 |
70 | ESMO consensus guidelines for the management of patients with metastatic colorectal cancer | Annals of Oncology | 2016 | 2,545 |
71 | Cancer treatment and survivorship statistics, 2014 | Ca-A Cancer Journal for Clinicians | 2014 | 2,474 |
72 | Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome | Blood | 1975 | 2,470 |
73 | Cancer treatment and survivorship statistics, 2012 | Ca-A Cancer Journal for Clinicians | 2012 | 2,467 |
74 | Revised International Prognostic Scoring System for Myelodysplastic Syndromes | Blood | 2012 | 2,458 |
75 | Epidermal growth factor-related peptides and their receptors in human malignancies | Critical Reviews in Oncology/Hematology | 1995 | 2,457 |
76 | The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial | Blood | 1998 | 2,441 |
77 | Leukocyte-endothelial adhesion molecules | Blood | 1994 | 2,428 |
78 | Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT | Blood | 2005 | 2,427 |
79 | LPS/TLR4 signal transduction pathway | Cytokine | 2008 | 2,424 |
80 | Clinical staging of chronic lymphocytic leukemia | Blood | 1975 | 2,423 |
81 | A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma | Blood | 1997 | 2,384 |
82 | Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia | Blood | 1999 | 2,376 |
83 | Colorectal cancer statistics, 2014 | Ca-A Cancer Journal for Clinicians | 2014 | 2,348 |
84 | International uniform response criteria for multiple myeloma | Leukemia | 2006 | 2,332 |
85 | Estimates of the cancer incidence and mortality in Europe in 2006 | Annals of Oncology | 2007 | 2,332 |
86 | Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia | Blood | 1999 | 2,291 |
87 | Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia | Blood | 1988 | 2,265 |
88 | American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography | Ca-A Cancer Journal for Clinicians | 2007 | 2,234 |
89 | Proposals for the classification of the myelodysplastic syndromes | British Journal of Haematology | 1982 | 2,230 |
90 | Ovarian cancer statistics, 2018 | Ca-A Cancer Journal for Clinicians | 2018 | 2,224 |
91 | Role of angiogenesis in tumor growth and metastasis | Seminars in Oncology | 2002 | 2,158 |
92 | Cancer statistics, 1998 | Ca-A Cancer Journal for Clinicians | 1998 | 2,145 |
93 | Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group | Blood | 2009 | 2,128 |
94 | The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 | Annals of Oncology | 2015 | 2,122 |
95 | Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors | Blood | 2000 | 2,090 |
96 | Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo | Experimental Hematology | 2002 | 2,084 |
97 | Current concepts in the diagnosis and management of cytokine release syndrome | Blood | 2014 | 2,080 |
98 | Breast cancer statistics, 2019 | Ca-A Cancer Journal for Clinicians | 2019 | 2,068 |
99 | Nomenclature of monocytes and dendritic cells in blood | Blood | 2010 | 2,046 |
100 | Interleukin-1 and interleukin-1 antagonism | Blood | 1991 | 2,044 |